M. Katori et M. Majima, Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors, INFLAMM RES, 49(8), 2000, pp. 367-392
In addition to housekeeping cyclooxygenase (COX)-1, which is constitutively
expressed in many body cells, an inducible COX-2 has been described and cl
oned. Induction or presence of COX-2 has been reported not only in isolated
cells, but also in cells in various tissues, as well as in both physiologi
cal and pathophysiological states, including acute exudative inflammation,
proliferative inflammation, animal arthritis, rheumatoid arthritis, angioge
nesis, bone absorption, gastric ulcer, colon cancer, hyperalgesia, Alzheime
r's disease and certain states of the kidney, brain and female reproductive
organs. This review article introduces results from recent works in these
fields. COX-1- or COX-2-knockout mice may provide many clues on the roles o
f COX-2, but may simultaneously cause unnecessary confusion in the recognit
ion of the roles of COX-2, and this is discussed. Recently the roles of COX
-2 in exudative inflammation and the anti-inflammatory effects of selective
COX-2 inhibitors have been questioned. This is discussed in the text. Pros
tanoids mediate signals to adjacent cells to provide fine regulation of cel
lular function. Because of the short duration of the expression of COX-2 ge
ne and protein, COX-2 must play some roles different from those of COX-1 ge
ne and protein in vivo. It is not yet possible to identify all the roles of
COX-2, but in some tissues, such as the kidney, the brain and others, COX-
2 may be expressed constitutively, whereas the prostaglandin generation by
COX-2 may replace that by COX-1 in some states (or vice-versa). Precise ana
lyses of the expression of COX-2 may disclose fine modulation of cellular a
nd organ functions by PGs.
Several selective or preferential COX-2 inhibitors have been developed and
were shown to be effective in clinical trials. Most were reported to be fre
e of adverse gastrointestinal effects, brit it should be noted that in the
healing process of gastric ulcers and in sodium-restricted states, adverse
effects of selective COX-2 inhibitors could be expected. Soon, with more de
tailed knowledge of the delicate roles of COX-2 in vivo, effective and safe
application of COX-2 inhibitors should be realized.